Stockholm3 wins EIT Innovators Award
Stockholm3, the new prostate cancer-detecting blood test, was awarded the €50,000 EIT Innovators Award at Budapests INNOVEIT conference.
This years EIT Innovators Award – recognizing innovation teams developing a product or service with a high potential for societal and economic impact – has been awarded Stockholm3, the new prostate cancer-detecting blood test.
– The Stockholm3 test allows us to find prostate cancer earlier, increasing detection with 20 percent and reducing the number of unnecessary biopsies by 50 percent with severe sideeffects such as sepsis, impotence and incontinence, says Martin Steinberg, project manager at Karolinska Institutet.
In choosing Stockholm3, for the prestigeous award the jury declared that the product “demonstrates uniqueness and originality ... and clearly addresses a market need in the medical field that potentially affects millions of individuals. The innovation has been tested and validated, and the expected societal and economic impact has the potential to be very high.”
– EIT Health has been a catalyst for this project, and with their support we are accelerating the implementation of Stockholm3, which has the potential to save 500,000 men from unnecessary treatments if implemented broadly in Europe. This award is very important to us, showing that we are on the right track and that what we are doing is important for Europe as a whole, says Martin Steinberg.
The award was given out in Budapest at the INNOVEIT conference, a key European innovation forum.
Also Read Stockholm3 at eithealth.eu
First Scandinavian CLC partner seminar in Malmö
2018-01-29January 31 EIT Health Scandinavian CLC will organize the first of a series of seminars for all Scandinavian partners. This 1st partner seminar will focus on the BP 2019 calls for project. ...
Andy Browning tillbaka till nya utmaningar
2018-01-24Hallå där… Andy Browning, som nu är tillbaka på jobbet som samverkansledare vid UU Innovation efter två år som EIT Health Director for Innovation Projects med placering i München. ...
Uppsala University granted 3 million SEK in innovation funding
2018-01-10With three million SEK from EIT Health, Peter Bergsten, Professor of Medical Cell Biology at Uppsala University, has joined DeTecT2D - the international innovation project aiming to provide diabetes h...
“EIT Health offers major resources and a unique European network”
2018-01-10Just a moment ... Krister Halldin and Titti Ekegren, project coordinators at the office for Medicine and Pharmacy, who assisted Peter Bergsten, Professor at Uppsala University, being granted 3 000 000...
Read Scandinavian CLC Newsletter December 2017
2017-12-21The December 2017 edition of the EIT Health Scandinavian CLC Newsletter is now online. Get current updates on the Calls for Proposals for 2019, the Scandinavian CLC Partners' Seminar January 31 and Ch...